10 Center Drive RM 13N240B Bethesda, MD 20892 Abbreviated Title : Enzalutamide in non-met CSPC CC Protocol #: 13-C-0153 NCT #: NCT01875250 OSP #:IBC #: 1301-1205RD-13-I-12 Amendment: J A Phase II Trial of Enzalutamide in Combination with PSA-TRICOM in Patients with Non-Metastatic Castration Sensitive Prostate Cancer NCI Principal Investigator:Ravi Madan, M.D. A, B, C, D, E, F Genitourinary Malignancies Branch, CCR, NCI 10 Center DriveBuilding 10, Room 13N240Bethesda, MD 20892Phone: (301) 480-7168Email: madanr@mail.nih.gov Statistician: Seth Steinberg, Ph.D., OCD, CCR, NCIE, F NIH Associate Investigators: James Gulley, M.D., PhD, GMB, CCR, NCIA, B, C, D, E, F William Dahut, M.D., GMB, CCR, NCIA, B, C, D, E, F Marijo Bilusic, M.D., PhD, GMB, CCR, NCIA, B, C, D, E, F Anna Couvillon, CRNP, GMB, CCR, NCIA, B, C, D, E, F Amy Hankin, P.A., GMB, CCR, NCI A, B, C, D, E, F Myrna Rauckhorst, R.N., OCD, CCR, NCIA, B, C, E, F Sheri McMahon, R.N., OCD, CCR, NCIA, B, C, E, F Jennifer Marte, M.D., GMB, CCR, NCIE, F Fatima Karzai, M.D., GMB, CCR, NCIA, B, C, D, E, F Julius Strauss, M.D., LTIB, CCR, NCIA, B, C, D, E, F Guinevere Chun, R.N., OCD, CCR, NCIA, B, C, E, F Helen Owens, R.N., OCD, CCR, NCIA, B, C, E, F Referral Contact: Study Coordinator: Anna Couvillon, C.R.N.P.Helen Owens, R.N., OCD, CCR, NCI 10 Center Drive, 13N244Bethesda, MD 20892Phone: 240-760-6068Email: helen.owens@nih.gov Non-NIH Associate Investigators: Philip M. Arlen, M.D. [V], GMB, CCR, NCIA, B, E, F Version Date: 12/5/17 Abbreviated Title : Enzalutamide in non-met CSPC 2Collaborators: Nima Sharifi, M.D.F,G Cleveland Clinic Foundation Lerner Research Institute9500 Euclid AvenueCleveland, Ohio 44195sharifn@ccf.org Roles: A. Obtain information by intervening or interacting with living individuals for research purposes B.